Safety assessment of extended adjuvant endocrine therapy with letrozole; results of the randomized phase III IDEAL trial (BOOG 2006-05)

Author(s):
Blok, E.J.; Kroep, J.R.; Kranenbarg, E.M.M.K.; Carpentier, M.D.D.; Putter, H.; Bosch, J. van den; Maartense, E.; Leeuwen-Stok, A.E. van; Liefers, G.J.; Nortier, J.W.R.; Rutgers, E.J.T.; Velde, C.J.H. van de (0000-0003-0104-1800)
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-02-28
Language
English
Is part of
Cancer Research
hdl
1887/114688
doi
10.1158/1538-7445.SABCS16-P2-09-08